首页> 外文OA文献 >Treatment of Hormone-Refractory Prostate Cancer with Docetaxel or Mitoxantrone: Relationships between Prostate-Specific Antigen, Pain, and Quality of Life Response and Survival in the TAX-327 Study

【2h】

Treatment of Hormone-Refractory Prostate Cancer with Docetaxel or Mitoxantrone: Relationships between Prostate-Specific Antigen, Pain, and Quality of Life Response and Survival in the TAX-327 Study

机译：用多西紫杉醇或米洛替兰松治疗激素 - 难治性前列腺癌：前列腺特异性抗原，疼痛和税收的生活质量与税收 - 327研究的关系

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Dominik R. Berthold; Gregory R. Pond; Martin Roessner; Ronald de Wit; Mario Eisenberger; and Ian F. Tannock;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Serum prostate-specific antigen decline as a marker of clinical outcome in hormone-refractory prostate cancer patients: association with progression-free survival, pain end points, and survival. [J] . Small EJ, McMillan A, Meyer M, Journal of Clinical Oncology . 2001,第5期

机译：血清前列腺特异性抗原的下降是激素难治性前列腺癌患者临床预后的标志：与无进展生存期，疼痛终点和生存期相关。
2. Clinical significance of a prostate-specific antigen flare phenomenon in patients with hormone-refractory prostate cancer receiving docetaxel. [J] . Olbert PJ, Hegele A, Kraeuter P, Anti-cancer drugs . 2006,第8期

机译：接受多西他赛治疗的激素难治性前列腺癌患者的前列腺特异性抗原耀斑现象的临床意义。
3. Editorial comment. Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer. [J] . Marc B Garnick BJU international . 2012,第8期

机译：编辑评论。对使用比卡鲁胺的联合雄激素阻断治疗的前列腺特异性抗原反应，可预测去势抵抗性前列腺癌患者随后接受雌激素和多西他赛治疗后的存活率。
4. Analysis of glycoforms of urinary prostate-specific antigen of prostate cancer and benign prostate hyperplasia samples [C] . Chun-Jen Hsiao, Tzong-Shin Tzai, Chein-Hung Chen, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：前列腺癌和良性前列腺增生样品的尿道前列腺特异性抗原糖族分析
5. Studies on human prostate-specific antigen as a tumor antigen for the immunotherapy of prostate cancer in a mouse model. [D] . Willis, Richard Allen. 2002

机译：人类前列腺特异性抗原作为一种肿瘤抗原的免疫模型在小鼠模型中的研究。
6. A systematic review of the effectiveness of docetaxel and mitoxantrone for the treatment of metastatic hormone-refractory prostate cancer [O] . R Collins, R Trowman, G Norman, 2006

机译：多西紫杉醇和米托蒽醌治疗转移性激素难治性前列腺癌的有效性的系统评价
7. Outcome of Patients with Hormone-Refractory Prostate Cancer: Prognostic Significance of Prostate-Specific Antigen-Doubling Time and Nadir Prostate-Specific Antigen [O] . S. Tomioka, M. Shimbo, Y. Amiya, 2008

机译：激素 - 难治性前列腺癌患者的结果：前列腺特异性抗原倍增时间和Nadir前列腺特异性抗原的预后意义
8. Predictive Biomarkers of Response to Bc1-2 Biomodulation by G3139 and Docetaxel in Hormone-Refractory Prostate Cancer [R] . Tolcher, A. W. 2005

机译：G3139和多西紫杉醇对激素难治性前列腺癌Bc1-2生物调节反应的预测生物标志物

Treatment of Hormone-Refractory Prostate Cancer with Docetaxel or Mitoxantrone: Relationships between Prostate-Specific Antigen, Pain, and Quality of Life Response and Survival in the TAX-327 Study

著录项

引文网络

相似文献

相关主题

期刊订阅